STAT+: In a rare move, FDA threatens to fine a company for failing to report clinical trial results
For only the fifth time, the U.S. Food and Drug Administration recently threatened to fine…
Category: Medicine
STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: With an age cutoff for a new gene therapy, families and doctors scramble to treat kids before their 6th birthday
In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had…
Opinion: Why it’s so difficult to count the number of heat-related deaths
In late July, as parts of the southern U.S. approached 30 days of temperatures exceeding…
Opinion: The CDC faces $1.5 billion in budget cuts. Layoffs will almost certainly follow
The nation’s health faces a dual threat — one anticipated, the other, self-inflicted. Covid-19 has…
.jpg)
Why drug shortages are having an outsize impact on ovarian cancer patients
Sarah Evans considers herself a lucky ovarian cancer patient, though she is dealing with the…
STAT+: FDA warns AstraZeneca over misleading promotional materials for a COPD drug
The U.S. Food and Drug Administration scolded AstraZeneca for making misleading claims about the effectiveness…
STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials
A U.S. government probe into a monkey-smuggling operation emanating from Cambodia has gone in a…
America’s ERs struggle with timely care for stroke patients
In the world of stroke care, time is everything. At stroke onset, a clot or…
YouTube cracks down on misinformation on cancer treatment
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Amazon Pharmacy offers insulin discounts; DOJ blasts industry attempt to delay Medicare drug-price talks
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
Radiation, a mainstay of cancer treatment, begins a fade-out
Every year, doctors get better tools to fight cancer. Engineered cancer-killing cells, immunotherapies, targeted drugs,…
STAT+: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
As Bristol Myers Squibb works to build its treatment for a heart condition that can…
Patient advocates warn FDA proposal on salt intake could do fatal harm to people with kidney disease
WASHINGTON — Patient advocates are warning that a recent proposal from the Food and Drug…
Opinion: Home blood pressure machines are often wrong. The FDA must speak up
Hypertension is considered to be the No. 1 risk factor for death globally. So it’s…
STAT+: From drug shortages to high prices, U.S. system’s shortcomings have deep roots
American medicine is a tragic paradox. An example: Cancer patients are likely dying as a…
Opinion: The best way for the NIH to reduce drug prices is to address drug spending
As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has…
STAT+: Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021
CommonSpirit Health, the massive not-for-profit health system formed through a 2019 merger, paid its former…
Mishmash of how U.S. heat deaths are counted complicates efforts to keep people safe as Earth warms
PHOENIX — Postal worker Eugene Gates Jr. was delivering mail in the suffocating Dallas heat…
Long-term exposure to particulates from wildfire smoke linked to dementia risk, new study finds
Smoke permeates everything and impacts everyone. The visible stew of carbon and particulates typically from…
STAT+: Pharmalittle: White House drug-shortage panel is MIA with lawmakers; Ultragenyx sued by Lacks family
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: What’s behind the recent surge in Apellis’ stock price? Growing confidence in the safety of its eye treatment
Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that…
STAT+: In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need
Emma Albee knows the experimental drug she takes is not a cure. It won’t allow…
STAT+: After Optum Health’s lowest profit margin in a decade, UnitedHealth makes changes
Just weeks after the division of UnitedHealth Group that provides care to patients posted its…
STAT+: Hospitals are dialing back on venture capital investing
Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in…
Listen: How Long Island became the ‘eugenics capital of the world’
The study of eugenics wasn’t born on Long Island — it’s closer to say it…
Opinion: I’m a dentist. I’m begging people not to give up on aspartame
The International Agency for Research on Cancer (IARC, an entity within the World Health Organization)…
STAT+: More hospital pharmacists are rationing drugs due to increasing shortages
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the…
STAT+: White House drug shortages task MIA with lawmakers while Congress works on fixes
WASHINGTON — A White House task force created to work on drug shortage reforms has…
Kim Kardashian sparks debate on the benefits of full-body MRI scans
The last time Kim Kardashian posted about medical imaging, it was to prove her butt…
STAT+: Pharmalittle: Supreme Court halts Purdue bankruptcy plan; what to know about compounded obesity drugs
And so, another working week will soon draw to a close. Not a moment too…
Bird flu researchers turn to Finland’s mink farms, tracking a virus with pandemic potential
HELSINKI — It was the quiet that stood out to Tarja Sironen at the fur…
Opinion: Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death
So many promising medical innovations never reach their full potential as therapies or cures, languishing…
Tuberculosis outbreak tied to bone grafts underscores shortcomings of testing
One person has died and at least four have been sickened by tuberculosis in infected…
STAT+: Supreme Court blocks Purdue bankruptcy plan that would shield Sacklers from lawsuits
The U.S. Supreme Court blocked a nationwide settlement with Purdue Pharma that was designed to…
.jpg)
STAT+: EPA fines Roche’s Genentech unit for hazardous waste violations
Following an extensive inspection, the U.S. Environmental Protection Agency fined Genentech more than $158,000 for…
STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’ that underpays out-of-network medical claims
AdventHealth, a large religious-affiliated hospital system, has sued MultiPlan, alleging the company has worked with…
STAT+: What to know about concerns raised about compounded versions of Novo Nordisk’s Wegovy
As demand for Ozempic and Wegovy surges, a little noticed warning about the medicines was…
Listen: Your guide to Wegovy’s blockbuster heart study
Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And…
Covid took a toll on heart health — and doctors are still grappling with how to help
ST. LOUIS — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear…
STAT+: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer
Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands…
Pharma budget tightening trickles down to Doximity
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: Anavex, maker of rare disease drug, keeps shifting the goalposts in its clinical trials
Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results…
STAT+: Novo acquires Inversago for up to $1 billion, spotlighting troubled weight loss approach
Fresh off of the news that its drug Wegovy may not just help people lose…
STAT+: Telehealth companies are driving a large share of weight loss drug prescriptions, claims data suggest
As a new class of obesity medications has soared in popularity, so have the online…
STAT+: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental…
Opinion: STAT+: What Mark Cuban gets wrong about prescription drugs
Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently…
How a beautiful symptom of a brutal dementia informs our understanding of creativity
Carol Spence’s vision is flooded with green. As her brush swoops right and swishes left,…
STAT+: Novo Nordisk celebrates landmark Wegovy study, even as supply issues persist
The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives…